Pharma Journalist -

AstraZeneca’s Calquence (acalabrutinib), a next generation, selective Bruton’s tyrosine kinase (BTK) inhibitor, has been approved in China for the treatment of adult patients with…
Read More...

GSK plc announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has accepted for review a supplementary new drug application (sJNDA) for Nucala (mepolizumab), a…
Read More...

Amgen and Horizon Therapeutics plc announced the entry into a consent order agreement with the Federal Trade Commission (FTC) that resolves the pending FTC administrative lawsuit. This…
Read More...

See the full summit details here. The 7th IPF Summit, a premier event in the field of pulmonary fibrosis research, is set to take place from September 19 to 21, 2023, in the vibrant…
Read More...

Pfizer Inc. and BioNTech SE announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended marketing authorization for…
Read More...

Embark Laboratories announced that Novo Nordisk has acquired Embark Biotech, including its lead metabolic program, and has entered a three-year research and development collaboration to…
Read More...

Zealand Pharma A/S, a biotechnology company focused on the discovery and development of innovative peptide-based medicines, announced that the US FDA has granted priority review…
Read More...

Roche announced that Tecentriq SC (atezolizumab) has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) in Great Britain. It will be provided by the…
Read More...

Roche announced today that the European Commission has approved the extension of the Evrysdi (risdiplam) European Union (EU) marketing authorisation to include infants with a clinical…
Read More...

Are you ready to embark on a transformative journey in the world of chromatography purification? Look no further than PURIFY'23 – the most anticipated event of the year for…
Read More...